94169-62-7

Basic information

• Product Name: METHYL 3,5-DIISOPROPYLOXYBENZOATE
• Synonyms: METHYL 3,5-DIISOPROPYLOXYBENZOATE;Methyl 3,5-diisopropoxybenzoate;3,5-Diisopropoxy-benzoic acid Methyl ester;3,5-bis(1-methylethoxy)Benzoic acid methyl ester
• CAS NO: 94169-62-7
• Molecular Formula: C₁₄H₂₀O₄
• Molecular Weight: 252.3062
• Product Categories: Esters;Phenyls & Phenyl-Het;Phenyls & Phenyl-Het
• Mol File: 94169-62-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 344.2 °C at 760 mmHg
• Flash Point: 148.8 °C
• Appearance: /
• Density: 1.042 g/cm³
• CAS DataBase Reference: METHYL 3,5-DIISOPROPYLOXYBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DIISOPROPYLOXYBENZOATE(94169-62-7)
• EPA Substance Registry System: METHYL 3,5-DIISOPROPYLOXYBENZOATE(94169-62-7)

Safety Data

• Hazardous Substances Data: 94169-62-7(Hazardous Substances Data)

Usage

General Description

METHYL 3,5-DIISOPROPYLOXYBENZOATE is a chemical compound that contains a benzene ring substituted with two isopropyl groups and an ester group. It is commonly used as a fragrance ingredient in cosmetic and personal care products, as well as in perfumes and colognes. The compound has a pleasant odor and is known for its ability to enhance the scent of other ingredients in a product. Additionally, it is used in the manufacturing of pharmaceuticals and as a flavoring agent in food products. However, it is important to handle this chemical with care and follow safety precautions, as it can be harmful if ingested or comes into contact with the skin or eyes.

Upstream product

• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 
• 75-26-3 isopropyl bromide 
• 75-30-9 2-iodo-propane 
• 752242-26-5 methyl 3-hydroxy-5-isopropoxybenzoate 

Downstream Products

• 94169-63-8 (3,5-diisopropoxyphenyl)methanol 
• 94169-64-9 3,5-diisopropyloxyphenylcarboxaldehyde 
• 94169-65-0 2-iodo-3,5-di-isopropoxybenzaldehyde 
• 94169-68-3 methyl 2'-iodo-3',5'-di-isopropoxy-4,5,6-trimethoxystylbene-3-carboxylate 
• 94169-69-4 methyl 2'-iodo-3',5'-di-isopropoxy-4,5,6-trimethoxystylbene-3-carboxylate 
• 150242-82-3 3,5-di-(isopropyloxy)benzoic acid 
• 942999-56-6 N-(tert-butyloxycarbonyl)-3,5-di-(isopropoxy)aniline 
• 942999-08-8 3,5-di-(isopropyloxy)aniline hydrochloride 
• 1006584-05-9 C₂₈H₄₀N₂O₆ 
• 1032435-05-4 N-[(3,5-diisopropoxy)phenyl] 4-[(2-amino)ethoxy]-3,5-dimethylbenzamide hydrochloride 
• 1093120-87-6 C₂₂H₂₃ClN₂O₄S 
• 1093120-99-0 C₂₃H₂₃N₃O₄S 
• 1093121-29-9 C₂₄H₂₆N₂O₆S 
• 1093120-82-1 C₂₃H₂₄N₂O₆S 

Relevant articles and documents

Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times

Ligand-target residence time is emerging as a key drug discovery parameter because it can reliably predict drug efficacy in vivo. Experimental approaches to binding and unbinding kinetics are nowadays available, but we still lack reliable computational to

Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator

Fragment-based lead discovery has been applied to urokinase-type plasminogen activator (uPA). The (R)-enantiomer of the orally active drug mexiletine 5 (a fragment hit from X-ray crystallographic screening) was the chemical starting point. Structure-aided

ASPARTYL PROTEASE INHIBITORS

The present invention provides compounds having formula (I): wherein R’, R0, R1, X1, R2, R3, R3’, X2, X3, and R4 are as defined herein, and pharmaceuticals compositions thereof. The present invention also provides methods of inhibiting proteases, more specially aspartyl proteases. In certain embodiments, compounds inhibit BACE (β-site APP-cleaving enzyme), and thus are useful in the treatment or prevention of a disease characterized by β-amyloid deposits in the brain (including, but not limited to, Alzheimer’s Disease). The present invention also provides methods for preparing compounds of the invention.